Home › Meningioma › New Hampshire
Meningioma clinical trials in New Hampshire
3 studies for Meningioma are looking for participants at sites in New Hampshire.
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT02523014Evaluation of the CONVIVO System
- Dartmouth-Hitchcock Medical Center, Lebanon
Recruiting
Ages 18 and older · All sexes · Updated Feb 6, 2026 · NCT05139277HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
- Dartmouth-Health Lebanon, Lebanon
Recruiting
Ages 18 and older · All sexes · Updated Nov 21, 2025 · NCT06930846From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.